A polymorphism in the angiogenesis inhibitor, endostatin, in lung cancer susceptibility

被引：10
|
作者：
Zambon, Lair [1 ]
Honma, Helen N. [1 ]
Lourenco, Gustavo J. [2 ]
Saad, Ivete A. B. [1 ]
Mussi, Ricardo K. [1 ]
Lima, Carmen S. P. [2 ]
机构：
[1] Univ Estadual Campinas, Fac Med Sci, Dept Internal Med, Pulm Unit, Campinas, SP, Brazil
[2] Univ Estadual Campinas, Fac Med Sci, Dept Internal Med, Clin Oncol Serv, Campinas, SP, Brazil
来源：
LUNG CANCER | 2008年 / 59卷 / 02期
关键词：
lung cancer; endostatin; D104N polymorphism; susceptibility;
D O I：
10.1016/j.lungcan.2007.10.018
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：276 / 278
页数：3
相关论文
共 50 条
  • [1] A polymorphism in the angiogenesis inhibitor, endostatin, in multiple myeloma
    Ortega, MM
    Nascimento, H
    Costa, FF
    Teori, MT
    Lima, CSP
    LEUKEMIA RESEARCH, 2003, 27 (01) : 93 - 94
  • [2] A polymorphism in the angiogenesis inhibitor, endostatin, in sporadic colorectal adenocarcinoma
    Helvia Nascimento
    Claudio Saddy Rodrigues Coy
    Juvenal Ricardo Navarro Góes
    Fernando Ferreira Costa
    Carmen Silvia Passos Lima
    International Journal of Colorectal Disease, 2004, 19 : 499 - 501
  • [3] Polymorphism in endostatin, an angiogenesis inhibitor, and prostate cancer risk and survival: A prospective study
    Mucci, Lorelei A.
    Stark, Jennifer R.
    Figg, William D.
    Schumacher, Fredrick
    Li, Haojie
    Abe, Miyako
    Hennessy, Kristen
    Stampfer, Meir J.
    Gaziano, John Michael
    Ma, Jing
    Kantoff, Philip W.
    INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (05) : 1143 - 1146
  • [4] A polymorphism in the angiogenesis inhibitor, endostatin, in sporadic colorectal adenocarcinoma
    Nascimento, H
    Coy, CSR
    Góes, JRN
    Costa, FF
    Lima, CSP
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2004, 19 (05) : 499 - 501
  • [5] Gene Therapy with the Angiogenesis Inhibitor Endostatin in an Orthotopic Lung Cancer Murine Model
    Ning, Tao
    Yan, Xi
    Lu, Ze-Jun
    Wang, Guo-Ping
    Zhang, Ning-Gang
    Yang, Jin-Liang
    Jiang, Sha-Sha
    Wu, Yang
    Yang, Li
    Guan, Yong-Song
    Luo, Feng
    HUMAN GENE THERAPY, 2009, 20 (02) : 103 - 111
  • [6] A polymorphism in endostatin, an angiogenesis inhibitor, predisposes for the development of prostatic adenocarcinoma
    Iughetti, P
    Suzuki, O
    Godoi, PHC
    Alves, VAF
    Sertié, AL
    Zorick, T
    Soares, F
    Camargo, A
    Moreira, ES
    di Loreto, C
    Moreira, CA
    Simpson, A
    Oliva, G
    Passos-Bueno, MR
    CANCER RESEARCH, 2001, 61 (20) : 7375 - 7378
  • [7] D104N polymorphism in endostatin, an angiogenesis inhibitor, in acute and chronic myeloid leukaemia
    Nascimento, Helvia
    Lourenco, Gustavo J.
    Ortega, Manoela M.
    Yamaguti, Gabriela G.
    Costa, Fernando F.
    Lima, Carmen S. P.
    LEUKEMIA RESEARCH, 2007, 31 (08) : 1158 - 1159
  • [8] Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
    OReilly, MS
    Boehm, T
    Shing, Y
    Fukai, N
    Vasios, G
    Lane, WS
    Flynn, E
    Birkhead, JR
    Olsen, BR
    Folkman, J
    CELL, 1997, 88 (02) : 277 - 285
  • [9] Hepatocytes synthesize the precursor of the angiogenesis inhibitor endostatin
    Cramer, T
    Bauer, M
    Herbst, H
    Bechstein, WO
    Neuhaus, P
    Ricken, EO
    Schuppan, D
    GASTROENTEROLOGY, 1997, 112 (04) : A1249 - A1249
  • [10] Angiogenesis inhibitor or aggressiveness marker? The function of endostatin in cancer through electrochemical biosensing
    Tejerina-Miranda, Sandra
    Pedrero, Maria
    Blazquez-Garcia, Marina
    Serafin, Veronica
    Montero-Calle, Ana
    Garranzo-Asensio, Maria
    Reviejo, A. Julio
    Pingarron, Jose M.
    Barderas, Rodrigo
    Campuzano, Susana
    BIOELECTROCHEMISTRY, 2024, 155
12345